|
Volumn 24, Issue 12, 2006, Pages 1481-1483
|
Towards cell therapy for diabetes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CELLS;
DISEASES;
DRUG THERAPY;
CELL THERAPY;
DIABETES;
HUMAN EMBRYONIC STEM CELLS;
BIOTECHNOLOGY;
2 OXOISOCAPROIC ACID;
C PEPTIDE;
CALCIUM CHANNEL;
CYCLIC AMP;
CYCLOPAMINE;
GLUCOSE;
INSULIN;
POTASSIUM CHANNEL;
PYRUVIC ACID;
TRANSCRIPTION FACTOR PDX 1;
CELL DIFFERENTIATION;
CELL PROLIFERATION;
CLINICAL PROTOCOL;
DIABETES MELLITUS;
EMBRYONIC STEM CELL;
ENDOCRINE CELL;
ENDODERM;
GENE EXPRESSION;
HUMAN;
INSULIN RELEASE;
MARKER GENE;
NEUROECTODERM;
NONHUMAN;
PANCREAS ISLET BETA CELL;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SHORT SURVEY;
STEM CELL TRANSPLANTATION;
CELL TRANSPLANTATION;
DIABETES MELLITUS;
EMBRYONIC STEM CELLS;
HUMANS;
INSULIN;
INSULIN-SECRETING CELLS;
ISLETS OF LANGERHANS;
PANCREAS;
|
EID: 33845696388
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1206-1481 Document Type: Short Survey |
Times cited : (37)
|
References (15)
|